#Latest news with #TakedaPharmaCNBC09-05-2025BusinessCNBCTakeda Pharma less impacted by tariff, yen headwinds than other Japanese drugmakers: CEOChristophe Weber, CEO of Takeda Pharma, discusses the group's plans to invest $30 billion into its U.S. operations over the next five years, saying the U.S. market remain crucial for the Japanese drugmaker regardless of the global tariff tensions.
CNBC09-05-2025BusinessCNBCTakeda Pharma less impacted by tariff, yen headwinds than other Japanese drugmakers: CEOChristophe Weber, CEO of Takeda Pharma, discusses the group's plans to invest $30 billion into its U.S. operations over the next five years, saying the U.S. market remain crucial for the Japanese drugmaker regardless of the global tariff tensions.
09-05-2025
